Labviva

Boston, MA · Founded 2017 · Privately Held (backing)

Developer of an AI-powered digital marketplace designed to offer visibility into life science supply chains. Labviva is based in Boston, MA and was founded in 2017. It was valued at $125 million at its later-stage round in Dec 2024, the last priced event on record. It has raised $55.1 million across 2 recorded rounds; the latest was an $8 million early-stage round in Jun 2021.

PMV mark · valuation
$125.0M
Oct 2026
Priced at
its later-stage round
Dec 2024
Total raised
$55.1M
Last round
Early Stage VC
Jun 2021
What is Labviva worth?
$125.0MPrivateMarketView mark · Oct 2026

Valued at $125.0M at its later-stage round, Dec 2024. Nothing has traded since.

Free account
More of Labviva with a free account
  • ·Watch Labviva: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Labviva funding history

2 rounds
DateRoundRaisedPost-money
Jun 2021Early Stage VC$8.0M▮
Apr 2019Seed Round$750K▮
Unlock post-money valuations

Membership and data by Private Market View

Labviva valuation

Labviva was valued at $125 million at its later-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Labviva raised?

Labviva has raised $55.1 million in total; 2 of its rounds are on record. The largest on record was an $8 million early-stage round in Jun 2021.

Labviva has filed 2 Form Ds with the SEC since 2019, most recently in Jun 2021 ($8 million sold to 3 investors).

How Labviva's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Labviva, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Labviva

What is Labviva worth?
Labviva is valued at $125.0M as of Oct 2026. Valued at $125.0M at its later-stage round, Dec 2024. Nothing has traded since.
How much has Labviva raised?
Labviva has raised $55.1M in total funding across 2 recorded rounds.
When did Labviva last raise?
Labviva last raised in Jun 2021 (Early Stage VC), raising $8.0M.